Opportunity Information: Apply for RFA CA 10 021

  • The National Institutes of Health in the education health sector is offering a public funding opportunity titled "Tumor Microenvironment Network (TMEN) (U54)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.393 Cancer Cause and Prevention Research 93.394 Cancer Detection and Diagnosis Research 93.395 Cancer Treatment Research 93.396 Cancer Biology Research 93.397 Cancer Centers Support Grants 93.398 Cancer Research Manpower 93.399 Cancer Control.
  • This funding opportunity was created on Oct 1, 2010 and posted on Sep 30, 2010.
  • Applicants must submit their applications by Jan 20, 2011. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • The funding agency has allocated a total of $10,450,000.00 to eligible and selected applicants.
  • Each selected applicant is eligible to receive up to $700,000.00 in funding.
  • Eligible applicants include: Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Others (see text field entitled Additional Information on Eligibility for clarification) Public and State controlled institutions of higher education County governments For profit organizations other than small businesses Private institutions of higher education State governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education City or township governments.
  • Other Eligible Applicants include the following U.S. Territory or Possession.
Apply for RFA CA 10 021

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Opportunity Summary:

The Tumor Microenvironment Network (TMEN) (U54) opportunity (Funding Opportunity Number RFA-CA-10-021) was a National Institutes of Health cooperative agreement solicitation led by the National Cancer Institute (NCI), with additional interest from the National Institute of Neurological Disorders and Stroke (NINDS). It was built around the idea that cancers are not driven only by malignant cells, but also by the surrounding "host" tissue and support systems, often referred to as the tumor microenvironment or stroma. The grant called for multi-investigator Research Centers that would function as connected pieces of a larger, interactive national network focused on understanding how stromal and other microenvironmental components influence tumor formation, tumor evolution, spread to distant sites, and responses to therapy.

The core scientific goals of TMEN were threefold. First, applicants were expected to advance a detailed, comprehensive understanding of what stromal tissue looks like in normal settings and how that baseline changes as tumors initiate, progress, and metastasize. Second, the network aimed to clarify the actual biological mechanisms behind tumor-stroma interactions specifically in human cancer, emphasizing mechanistic insight rather than purely descriptive work. Third, TMEN sought to identify how stromal elements and microenvironmental conditions influence treatment response, including why some therapies fail, how resistance emerges, and how microenvironment-focused interventions might improve outcomes. Alongside these NCI priorities, NINDS highlighted a particular interest in research programs that address primary brain tumors or peripheral nervous system tumors, meaning proposals with strong relevance to nervous system oncology were especially aligned with NINDS priorities.

A defining feature of this FOA was that it did not just fund independent research projects operating in parallel. Because it used the U54 cooperative agreement mechanism, funded centers were expected to work closely with NIH program staff and, importantly, with each other as a coordinated network. The solicitation explicitly required participation in collaborative network-wide efforts that would be developed within TMEN, with an emphasis on building shared capabilities for the broader field. These collaborative expectations centered on three main activities: developing and distributing resources and reagents that are critical for analyzing the tumor microenvironment; creating and refining new technologies that make microenvironment research more powerful, more quantitative, or more accessible; and conducting outreach so that the tools, datasets, reagents, and methods created by TMEN do not stay confined to the funded centers but instead spread to the wider research community.

The TMEN program also emphasized infrastructure and community utility. Funded centers were expected to help establish repositories of important reagents, resources, and information, effectively serving as hubs that other investigators could rely on for standardized materials and shared data. In practice, this kind of requirement typically points to activities such as maintaining banks of validated antibodies, cell lines, stromal components, animal models, imaging tools, analytical pipelines, well-annotated tissue resources, or interoperable datasets, along with documentation and sharing plans. The network structure was intended to promote interdisciplinary collaboration, both within TMEN and with outside groups, reflecting the reality that tumor microenvironment research often spans cancer biology, immunology, engineering, computational analysis, pathology, imaging, and clinical oncology.

From an administrative standpoint, the opportunity was categorized as discretionary funding and a cooperative agreement, with activity in health and education-related research areas. It listed multiple CFDA numbers tied to cancer research and support programs (93.393 through 93.399). There was no cost-sharing or matching requirement. The FOA was posted on September 30, 2010, and had an original and current closing date of January 20, 2011, with an archive date of February 20, 2011, indicating this was a time-limited solicitation that is no longer open.

In terms of funding scale, the FOA listed an estimated total funding of $10,450,000 and an award ceiling of $700,000. Eligibility was broad across U.S.-based organizational types, including public and state-controlled institutions of higher education, private institutions of higher education, nonprofits with or without 501(c)(3) status, for-profit organizations other than small businesses, and various levels of government (state, county, city/township), with additional eligibility extending to U.S. territories or possessions as noted in the eligibility information. The practical takeaway is that the opportunity was designed for substantial, organized research center applications rather than single-investigator grants, and it favored teams that could demonstrate both deep scientific programs in tumor microenvironment biology and a credible plan to contribute shared tools, technologies, and outreach as active members of a coordinated national network.

For reference, the full announcement was hosted through the NIH grants guide at the link provided in the source, and technical access issues were routed to the NIH Office of Extramural Research webmaster contact listed in the notice.

Frequently Asked Questions (FAQs): Tumor Microenvironment Network (TMEN) (U54) - RFA-CA-10-021

What is the Tumor Microenvironment Network (TMEN) (U54) funding opportunity?

TMEN (U54) was a National Institutes of Health (NIH) cooperative agreement funding opportunity led by the National Cancer Institute (NCI), with additional interest from the National Institute of Neurological Disorders and Stroke (NINDS). It solicited multi-investigator Research Centers intended to operate as connected parts of a larger national network focused on the tumor microenvironment (also called the stroma) and its role in cancer.

What is the Funding Opportunity Number (FOA number) for this solicitation?

The Funding Opportunity Number was RFA-CA-10-021.

Which NIH institutes were involved?

The solicitation was led by the National Cancer Institute (NCI), with additional interest from the National Institute of Neurological Disorders and Stroke (NINDS).

What central idea or scientific premise did TMEN focus on?

TMEN was built around the idea that cancers are driven not only by malignant tumor cells, but also by surrounding "host" tissues and support systems, collectively referred to as the tumor microenvironment or stroma. The program emphasized understanding how these non-malignant components influence tumor behavior and treatment outcomes.

What kinds of awards were sought (single projects or centers)?

The FOA called for multi-investigator Research Centers rather than independent single-investigator projects. Funded centers were expected to function as coordinated components of an interactive national network.

What does "U54 cooperative agreement" mean in the context of this opportunity?

This opportunity used the U54 cooperative agreement mechanism. Based on the solicitation description, that meant funded centers were expected to work closely with NIH program staff and with each other as a coordinated network, rather than operating as fully independent, parallel projects.

What were the core scientific goals of TMEN?

The program described three core goals: (1) build a detailed, comprehensive understanding of what stromal tissue looks like in normal settings and how that baseline changes as tumors initiate, progress, and metastasize; (2) clarify the biological mechanisms behind tumor-stroma interactions specifically in human cancer, emphasizing mechanistic insight rather than purely descriptive work; and (3) identify how stromal elements and microenvironmental conditions influence treatment response, including therapy failure, resistance, and opportunities for microenvironment-focused interventions to improve outcomes.

Did the FOA emphasize descriptive characterization or mechanistic research?

The FOA emphasized mechanistic insight, particularly for tumor-stroma interactions in human cancer, rather than purely descriptive studies.

What aspects of cancer biology was TMEN trying to understand?

TMEN aimed to understand how microenvironmental and stromal components influence tumor formation, tumor evolution, spread to distant sites (metastasis), and responses to therapy.

How did the FOA address treatment response and therapeutic resistance?

The program specifically sought to identify how stromal elements and microenvironmental conditions influence treatment response, including why some therapies fail, how resistance emerges, and how interventions targeting the microenvironment might improve outcomes.

What research areas were especially aligned with NINDS priorities?

NINDS highlighted a particular interest in research programs addressing primary brain tumors or peripheral nervous system tumors. Proposals with strong relevance to nervous system oncology were especially aligned with those priorities.

Were awardees expected to collaborate with each other, or could each center work independently?

A defining feature was that it did not fund independent projects operating in parallel. Funded centers were explicitly required to participate in collaborative, network-wide efforts developed within TMEN and to act as coordinated members of the national network.

What kinds of network-wide collaborative activities were required?

The FOA emphasized three main collaborative activities: (1) developing and distributing resources and reagents critical for analyzing the tumor microenvironment; (2) creating and refining new technologies that make microenvironment research more powerful, quantitative, or accessible; and (3) conducting outreach so TMEN-created tools, datasets, reagents, and methods spread to the wider research community.

What did the FOA mean by "resources and reagents" for tumor microenvironment research?

The solicitation described an expectation to develop and distribute resources and reagents critical for analyzing the tumor microenvironment. It also emphasized establishing repositories of important reagents, resources, and information that other investigators could rely on for standardized materials and shared data.

Did TMEN include outreach requirements?

Yes. Outreach was an explicit emphasis, with the goal that tools, datasets, reagents, and methods created by TMEN would spread beyond the funded centers to the broader research community.

Were centers expected to serve as hubs or repositories?

Yes. The program emphasized infrastructure and community utility, expecting centers to help establish repositories of important reagents, resources, and information, effectively functioning as hubs for standardized materials and shared data.

What kinds of disciplines did TMEN expect to bring together?

The FOA indicated the network structure was intended to promote interdisciplinary collaboration, reflecting that tumor microenvironment research can span cancer biology, immunology, engineering, computational analysis, pathology, imaging, and clinical oncology.

What was the funding type and general category of this opportunity?

Administratively, the opportunity was described as discretionary funding and a cooperative agreement, with activity in health and education-related research areas.

Which CFDA numbers were associated with this FOA?

The opportunity listed multiple CFDA numbers tied to cancer research and support programs: 93.393 through 93.399.

Was cost sharing or matching required?

No. The FOA stated there was no cost-sharing or matching requirement.

When was this FOA posted, and when did it close?

The FOA was posted on September 30, 2010. The original and current closing date was January 20, 2011. The archive date was February 20, 2011.

Is this funding opportunity still open?

No. The dates provided (closing date January 20, 2011, archive date February 20, 2011) indicate it was a time-limited solicitation and is no longer open.

What was the estimated total funding amount for the FOA?

The FOA listed estimated total funding of $10,450,000.

What was the award ceiling?

The FOA listed an award ceiling of $700,000.

Who was eligible to apply?

Eligibility was broad across U.S.-based organizational types, including public and state-controlled institutions of higher education, private institutions of higher education, nonprofits with or without 501(c)(3) status, for-profit organizations other than small businesses, and various levels of government (state, county, city/township). The eligibility information also extended to U.S. territories or possessions as noted in the FOA.

Was the opportunity intended for small, single-lab applications?

No. The practical takeaway described in the notice was that the opportunity was designed for substantial, organized research center applications rather than single-investigator grants, favoring teams that could deliver both deep scientific programs and network contributions (shared tools, technologies, and outreach).

Where could applicants find the full announcement and official details?

The full announcement was hosted through the NIH Grants Guide at the link provided in the source notice.

Where were technical access issues directed?

Technical access issues were routed to the NIH Office of Extramural Research webmaster contact listed in the notice.

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Education Health

Next opportunity: The NSF Census Research Network

Previous opportunity: Plant Genome Research Program

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for RFA CA 10 021

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (RFA CA 10 021) also looked into and applied for these:

Funding Opportunity
Animal and Biological Material Resource Centers (P40) Apply for PAR 11 001

Funding Number: PAR 11 001
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Cancer Center Support Grants (CCSGs) for NCI designated Cancer Centers (P30) Apply for PAR 11 005

Funding Number: PAR 11 005
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Comprehensive Partnerships to Reduce Cancer Health Disparities (U54) Apply for RFA CA 11 001

Funding Number: RFA CA 11 001
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Translational Scholar Career Awards in Pharmacogenomics and Personalized Medicine (K23) Apply for PA 11 009

Funding Number: PA 11 009
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $200,000
Substance Use and Abuse, Risky Decision Making and HIV/AIDS (R03) Apply for PA 11 008

Funding Number: PA 11 008
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Substance Use and Abuse, Risky Decision Making and HIV/AIDS (R01) Apply for PA 11 006

Funding Number: PA 11 006
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Substance Use and Abuse, Risky Decision Making and HIV/AIDS (R21) Apply for PA 11 007

Funding Number: PA 11 007
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $200,000
HIV Infection of the Central Nervous System (R01) Apply for PA 11 014

Funding Number: PA 11 014
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
National Gene Vector Biorepository and Coordinating Center (P40) Apply for RFA RR 10 010

Funding Number: RFA RR 10 010
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Medical Marijuana Policy Research Exploring Trends and Impacts (R01) Apply for RFA DA 11 008

Funding Number: RFA DA 11 008
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $500,000
Molecular Genetics of Drug Addiction and Related Co Morbidities (R01) Apply for PA 11 026

Funding Number: PA 11 026
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Support Opportunity for Addiction Research (SOAR) for New Investigators (R03) Apply for RFA DA 11 010

Funding Number: RFA DA 11 010
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
The Development Of Frontal Cortex And Limbic System And Their Roles In Drug Abuse (R01) Apply for PA 11 027

Funding Number: PA 11 027
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Continued Development and Maintenance of Software (R01) Apply for PAR 11 028

Funding Number: PAR 11 028
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Statistical Coordination Center for the Population based Research Optimizing Screening through Personalized Regimens (PROSPR)(U01) Apply for RFA CA 11 004

Funding Number: RFA CA 11 004
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Population based Research Optimizing Screening through Personalized Regimens (PROSPR) (U54) Apply for RFA CA 11 003

Funding Number: RFA CA 11 003
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Functional Genetics, Epigenetics, and Non coding RNAs in Drug Addiction (R21) Apply for PA 11 034

Funding Number: PA 11 034
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $275,000
Functional Genetics, Epigenetics, and Non coding RNAs in Drug Addiction (R03) Apply for PA 11 035

Funding Number: PA 11 035
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Institutional Clinical and Translational Science Award (U54) Apply for RFA RM 10 020

Funding Number: RFA RM 10 020
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Limited Competition Fogarty International Research Collaboration Behavioral and Social Sciences (FIRCA BSS) Research Award (R03) Apply for PAR 11 036

Funding Number: PAR 11 036
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

USGrants.org applicant portal membership

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "RFA CA 10 021", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.